Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Rosemont Pharmaceuticals Ltd, Yorkdale Industrial Park, Braithwaite Street, Leeds, LS11 9XE, UK
Frusol 20mg/5ml Oral Solution.
| Pharmaceutical Form |
|---|
|
A clear yellow liquid (Oral Solution). |
Each 5ml contains 20 milligrams Furosemide.
Excipient(s) with known effect:
Ethanol 397.28mg/5ml
Quinoline Yellow (E104) 0.075mg/5ml
Liquid Maltitol (E965) 2.5g/5ml
Propylene Glycol (E1520) 0.35mg/5ml
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Furosemide |
Furosemide inhibits active chloride transport in the thick ascending limb. Re-absorption of sodium, chloride from the nephron is reduced and a hypotonic or isotonic urine produced. The evidence from many experimental studies suggests that furosemide acts along the entire nephron with the exception of the distal exchange site. |
| List of Excipients |
|---|
|
Ethanol |
Bottles: Amber (Type III) glass.
Closures: HDPE, EPE wadded, tamper evident, child resistant.
Capacity: 150ml.
Rosemont Pharmaceuticals Ltd, Yorkdale Industrial Park, Braithwaite Street, Leeds, LS11 9XE, UK
PL 00427/0109
Date of first authorisation: 06 April 1998
Date of latest renewal: 31 March 2003
| Drug | Countries | |
|---|---|---|
| FRUSOL | Cyprus, Estonia, Malta, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
